| 000 | 01730 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250515234221.0 | ||
| 264 | 0 | _c20110114 | |
| 008 | 201101s 0 0 eng d | ||
| 022 | _a1873-2623 | ||
| 024 | 7 |
_a10.1016/j.transproceed.2010.05.121 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGirman, P | |
| 245 | 0 | 0 |
_aSimilar early complication rate in simultaneous pancreas and kidney recipients on tacrolimus/mycophenolate mofetil versus tacrolimus/sirolimus immunosuppressive regimens. _h[electronic resource] |
| 260 |
_bTransplantation proceedings _c |
||
| 300 |
_a1999-2002 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aBrain Death |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 1 _xsurgery |
| 650 | 0 | 4 |
_aDiabetic Nephropathies _xsurgery |
| 650 | 0 | 4 | _aHospitalization |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunosuppressive Agents _xadverse effects |
| 650 | 0 | 4 |
_aKidney Failure, Chronic _xsurgery |
| 650 | 0 | 4 |
_aKidney Transplantation _xadverse effects |
| 650 | 0 | 4 | _aLength of Stay |
| 650 | 0 | 4 |
_aMycophenolic Acid _xadverse effects |
| 650 | 0 | 4 |
_aPancreas Transplantation _xadverse effects |
| 650 | 0 | 4 |
_aPostoperative Complications _xepidemiology |
| 650 | 0 | 4 |
_aSirolimus _xadverse effects |
| 650 | 0 | 4 |
_aTacrolimus _xadverse effects |
| 650 | 0 | 4 | _aTissue Donors |
| 700 | 1 | _aLipar, K | |
| 700 | 1 | _aKoznarova, R | |
| 700 | 1 | _aBoucek, P | |
| 700 | 1 | _aKriz, J | |
| 700 | 1 | _aKocik, M | |
| 700 | 1 | _aHavrdova, T | |
| 700 | 1 | _aAdamec, M | |
| 700 | 1 | _aSaudek, F | |
| 773 | 0 |
_tTransplantation proceedings _gvol. 42 _gno. 6 _gp. 1999-2002 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.transproceed.2010.05.121 _zAvailable from publisher's website |
| 999 |
_c20030865 _d20030865 |
||